These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6785551)

  • 1. Relation between the HDL apoproteins and AI isoproteins in subjects with the AIMilano abnormality.
    Franceschini G; Sirtori M; Gianfranceschi G; Sirtori CR
    Metabolism; 1981 May; 30(5):502-9. PubMed ID: 6785551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of the phenotypic expression of the A-IMilano apoprotein with plasma lipid and lipoprotein patterns.
    Franceschini G; Sirtori CR; Bosisio E; Gualandri V; Orsini GB; Mogavero AM; Capurso A
    Atherosclerosis; 1985 Dec; 58(1-3):159-74. PubMed ID: 3937534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
    J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.
    Franceschini G; Sirtori CR; Capurso A; Weisgraber KH; Mahley RW
    J Clin Invest; 1980 Nov; 66(5):892-900. PubMed ID: 7430351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
    Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
    Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased apoprotein B in very low density lipoproteins of patients with peripheral vascular disease.
    Franceschini G; Bondioli A; Mantero M; Sirtori M; Tattoni G; Biasi G; Sirtori CR
    Arteriosclerosis; 1982; 2(1):74-80. PubMed ID: 7059324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein AIMilano. (The first molecular variant of human apolipoproteins).
    Sirtori CR; Franceschini G
    Ric Clin Lab; 1982; 12(1):83-6. PubMed ID: 6806888
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction.
    Durrington PN; Hunt L; Ishola M; Kane J; Stephens WP
    Br Heart J; 1986 Sep; 56(3):206-12. PubMed ID: 3092846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Separation of high density lipoproteins (HDL) using zonal ultracentrifugation in patients with apolipoprotein AI Milano variant].
    Noseda G; Fragiacomo C; Cairoli R; Margon L; Franceschini G; Sirtori CR
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1933-5. PubMed ID: 6420885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the distribution and composition of high-density lipoproteins in primary hypothyroidism.
    Muls E; Rosseneu M; Lamberigts G; De Moor P
    Metabolism; 1985 Apr; 34(4):345-53. PubMed ID: 3920475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
    Muls E; Rosseneu M; Bury J; Stul M; Lamberigts G; De Moor P
    J Clin Endocrinol Metab; 1985 Nov; 61(5):882-9. PubMed ID: 3930554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma high-density lipoprotein metabolism in subjects with primary hypertriglyceridaemia: altered metabolism of apoproteins AI and AII.
    Rao SN; Magill PJ; Miller NE; Lewis B
    Clin Sci (Lond); 1980 Nov; 59(5):359-67. PubMed ID: 7428302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired catabolism of very low-density lipoprotein-triglyceride in a family with primary hypertriglyceridemia.
    Dunn FL; Grundy SM; Bilheimer DW; Havel RJ; Raskin P
    Metabolism; 1985 Apr; 34(4):316-24. PubMed ID: 3884962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.
    Eisenberg S; Gavish D; Oschry Y; Fainaru M; Deckelbaum RJ
    J Clin Invest; 1984 Aug; 74(2):470-82. PubMed ID: 6378975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High density lipoprotein metabolism in a patient with abetalipoproteninemia.
    Illingworth DR; Connor WE; Alaupovic P
    Ann Nutr Metab; 1981; 25(1):1-10. PubMed ID: 6789759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.
    Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES
    Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.